Elixinol Global Sales Rise to A$8 Million in Q2 | CashCropToday
0 Shares 386 Views

Elixinol Global Sales Rise to A$8 Million in Q2

July 30, 2018
386 Views

Elixinol Global (ASX: EXL) (OTC: ELLXF), an Australian based hemp Cannabidiol (CBD) product manufacturing and distribution company, announced their Q2 financial results today. Elixinol has impressively reported sales of A$8.0 million, which is a reported growth of 111% from last year.

Elixinol sells a variety of premium CBD products in the form of cosmetics, topical’s, tinctures, capsules, and pet products. The company’s headquarters is located out of Australia but, currently has distribution networks setup in the United States, Europe, South America, and Japan, where just this year Elixinol was accepted as the first CBD company to distribute and market in the country.

Elixinol has also recently joint ventured with Kersey Ag to complete the cultivation of high- yielding CBD industrial hemp in Colorado. Their newly founded company, Northern Colorado High Plains Producers completed its first planting of hemp in April 2018. Elixinol plans to cultivate industrial hemp in Colorado in the hopes of establishing a extraction and manufacturing facility for their product line in the United States.

The company is currently trading at $1.41AUD per share and has a market cap of 146.159 million dollars.

You may be interested

OTC Markets Group Welcomes TerrAscend Corp. to OTCQX
Market Watch
10 views
Market Watch
10 views

OTC Markets Group Welcomes TerrAscend Corp. to OTCQX

Jaelynn Offerman - October 22, 2018

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced TerrAscend Corp. (CSE: TER; OTCQX: TRSSF), a biopharmaceutical and wellness company that…

Pivot Pharmaceuticals Signs Agreement with Licorera Del Sur Subsidiary Cartagena Inc. To Create Joint Venture To Commercialize Cannabis-Infused Non-Alcoholic Beverages
Global
8 views
Global
8 views

Pivot Pharmaceuticals Signs Agreement with Licorera Del Sur Subsidiary Cartagena Inc. To Create Joint Venture To Commercialize Cannabis-Infused Non-Alcoholic Beverages

Jaelynn Offerman - October 22, 2018

Pivot Pharmaceuticals, Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has signed a Letter of Intent to create a Joint Venture…

MedMen to Sell Three Retail Locations to Treehouse Real Estate for $12.5M
Market Watch
43 views
Market Watch
43 views

MedMen to Sell Three Retail Locations to Treehouse Real Estate for $12.5M

Editor - October 19, 2018

MedMen Enterprises Inc. (CSE: MMEN) (OTCQB: MMNFF) announced this week that the company has agreed to sell three seperate cannabis retail locations to Treehouse Real Estate Investment…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: